Assignee
ASHVATTHA THERAPEUTICS INC
US·3 granted patents·8 pending applications·2 citations·filing 2020–2024
Top patents by PatentIndex Score
11 records- 0185US11612660B2Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·2 cites·19 claims
- 0283US2025242037A1Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0382US12121585B2Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·20 claims
- 0472US2025009894A1Dendrimer compositions and methods for treatment of severe acute respiratory distress syndromeASHVATTHA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0566US11931418B2Methods of treating severe inflammationASHVATTHA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·0 cites·29 claims
- 0660US2021170040A1Dendrimer compositions and methods for drug deliveryASHVATTHA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0757US2023226199A1Dendrimer compositions and methods for drug deliveryASHVATTHA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0857US2025009893A1Dendrimer conjugates and methods of use thereofASHVATTHA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0953US2023364244A1Dendrimer compositions and methods for drug delivery to injured kidneyASHVATTHA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1050US2024252695A9Radiolabeled ether dendrimer conjugates for pet imaging and radiotherapyASHVATTHA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1146US2023233696A1Triantennary n-acetylgalactosamine modified hydroxyl polyamidoamine dendrimers and methods of use thereofASHVATTHA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →